| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
S45056-50mg促销 |
≥98% | ￥114.00 ￥102.00 |
10 | 4 | 2 | - | - |
|
S45056-250mg促销 |
≥98% | ￥490.00 ￥440.00 |
10 | - | 1 | - | - |
|
S45056-1g促销 |
≥98% | ￥1110.00 ￥999.00 |
10 | - | - | - | - |
|
Laquinimod (ABR-215062), an orally available carboxamide derivative, is a potent immunomodulator which prevents neurodegeneration and inflammation in the central nervous system. Laquinimod reduces astrocytic NF-κB activation to protect from Cuprizone-induced demyelination. Laquinimod has the potential for relapsing remitting (RR) and chronic progressive (CP) forms of multiple sclerosis (MS; RRMS or CPMS) as well as neurodegenerative diseases research
| SMILES： | C1=CC=C(Cl)C2=C1N(C(=C(C2=O)C(=O)N(CC)C3=CC=CC=C3)O)C |
|---|---|
| 沸点： | 471.9℃ at 760mmHg |
| 溶解性： | Soluble in DMSO |
| 储存条件： | -20℃ |
| 用途： | 本品仅供科研，不得用于其它用途。 |
| 密度： | 1.395 |
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京